Engineers Gate Manager LP Sesen Bio, Inc. Transaction History

Engineers Gate Manager LP

  • $7.46 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.58 - $0.86 $30,681 - $45,494
-52,900 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.73 - $1.28 $38,617 - $67,712
52,900 New
52,900 $43,000
Q2 2021

Aug 16, 2021
SELL
$2.18 - $4.66 $37,932 - $81,084
-17,400 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.3 - $3.24 $22,620 - $56,376
17,400 New
17,400 $45,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email